Workflow
VCI Global to Present Sovereign Data Infrastructure at ASEAN AI Summit 2025
Globenewswire· 2025-07-31 03:30
Chief AI Security Officer Jane Teh to Deliver Landmark Keynote on Encrypted Compute and Digital SovereigntyKUALA LUMPUR, Malaysia, July 30, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a cross-sector platform builder integrating deep technology with financial architecture to enable sovereign-ready digital ecosystems, announced today that it will present its flagship Sovereign Data Infrastructure at the ASEAN AI Summit 2025, taking place from August 12–13, 2025, ...
Freddie Mac Announces Release Date for Second Quarter 2025 Financial Results
Globenewswire· 2025-07-31 03:28
MCLEAN, Va., July 30, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB:FMCC) announced today that it plans to report its Second Quarter 2025 financial results before the U.S. financial markets open on Thursday, July 31, 2025. The company will hold a call at 9 a.m. Eastern Time (ET) on Thursday, July 31, 2025, to share the company’s results with the media. The call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days. All materials related to the call w ...
Why Is Cardiff Oncology Stock Trading Lower After Colorectal Cancer Data?
Benzinga· 2025-07-31 03:27
核心观点 - 公司Cardiff Oncology Inc CRDF公布CRDF-004 Phase 2临床试验数据 显示onvansertib联合标准疗法SoC在RAS突变转移性结直肠癌mCRC一线治疗中表现出较高客观缓解率ORR和潜在疗效 [1][2][3] - 高剂量30mg onvansertib组ORR达59% 显著高于对照组43% 且肿瘤缩小程度更深 [2][4] - 分析师认为当前估值未充分反映药物临床潜力 机构William Blair看好其可能改变RAS突变mCRC一线治疗格局 [10] 临床试验设计 - 试验采用六组随机设计 包括20mg/30mg onvansertib+SoC及单独SoC对照组 [2] - 中位随访6个月时 20mg和30mg组均显示比对照组更早的无进展生存期PFS曲线分离 [5] 疗效数据 - 30mg组确认ORR为49% 20mg组42% 均高于对照组30% [2] - 历史数据显示ORR提升11%-20%可转化为PFS和总生存期获益 暗示onvansertib可能达到关键试验终点 [9] 安全性表现 - 104名患者安全性分析显示onvansertib联合化疗和贝伐珠单抗耐受性良好 未出现重大意外毒性 [6] - 3级及以上不良事件罕见 最常见为中性粒细胞减少症 [7] 研发进展 - 一线mCRC项目更新预计2026年第一季度公布 [7] - 现有数据支持推进Phase 3试验 机构建议加大投资 [7][10] 市场反应 - 公司股价当日下跌19 94%至2 65美元 但分析师认为空方论点已被数据削弱 [8][10]
Banco Santander Q2 Earnings: Another Record Bottom Line
Seeking Alpha· 2025-07-31 03:27
Spain's Banco Santander (NYSE: SAN ) continues to enjoy an excellent 2025, with the ADSs of this multinational banking giant returning another ~25% since my last update in May. That brings the stock's total year-to-date return to the 100% mark, comfortably outpacingI like to take a long term, buy-and-hold approach to investing, with a bias toward stocks that can sustainably post high quality earnings. Mostly found in the dividend and income section. Blog about various US/Canadian stocks at 'The Compound Inv ...
Trex Simplifies Railing Specification With Interactive Design Tool
Globenewswire· 2025-07-31 03:26
Advanced 3D Configurator Streamlines Selection, Quoting and Materials Estimation Trex Simplifies Railing Specification with Interactive Design Tool Trex Deck Railing Designer. WINCHESTER, Va., July 30, 2025 (GLOBE NEWSWIRE) -- In an effort to simplify the railing selection process for trade professionals and homeowners, Trex Company [NYSE:TREX], the world’s largest manufacturer of high-performance, low-maintenance composite decking and residential railing, has launched the new Trex® Deck Railing Design ...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Petco Health and Wellness Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WOOF
GlobeNewswire News Room· 2025-07-31 03:23
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) between January 14, 2021 and June 5, 2025, both dates inclusive (the “Class Period”), of the important August 29, 2025 lead plaintiff deadline. SO WHAT: If you purchased Petco securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency ...
Polaris Analysts Boost Their Forecasts After Better-Than-Expected Q2 Earnings
Benzinga· 2025-07-31 03:22
公司业绩 - 第二季度调整后每股收益为40美分 远超市场预期的每股亏损4美分 [1] - 季度销售额达18.52亿美元 高于市场预期的17.20亿美元 [1] - 第三季度销售额指引为16.00亿至18.00亿美元 高于市场预期的16.71亿美元 [1] - 财报公布后股价单日上涨7.8%至53.32美元 [1] 分析师评级调整 - Baird将目标价从46美元上调至55美元 维持中性评级 [4] - RBC Capital将目标价从34美元大幅上调至56美元 维持行业一致评级 [4] - MO Capital将目标价从33美元上调至52美元 维持市场表现评级 [4] 市场反应 - 多家机构在财报后同步上调目标价 最高调整幅度达64.7%(RBC Capital从34→56美元) [4] - 所有调整后的目标价均高于财报公布前的股价水平 [1][4]
Rocky Brands Q2: Thriving In Tariff Turmoil
Seeking Alpha· 2025-07-31 03:21
Rocky Brands, Inc. (NASDAQ: RCKY ) reported great Q2 results, sending the stock surging. The boot and other footwear manufacturer and seller showed strong sales momentum in the quarter, trickling down to earnings. Even more impressively, Rocky even raised the company’s 2025I am an avid investor with a major focus on small cap companies with experience in investing in US, Canadian, and European markets. My investment philosophy to generating great returns on the stock market revolves around identifying mispr ...
Cracking the alchemist's code: fusion energy company looks to turn mercury into gold
KITCO· 2025-07-31 03:21
Neils ChristensenNeils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada. He has worked exclusively within the financial sector since 2007, when he started with the Canadian Economic Press. Neils can be contacted at: 1 866 925 4826 ext. 1526 nchristensen at kitco.com @Neils_cShareDisclaimer: The views expressed ...
Procter & Gamble Q4 Earnings: Deceleration Of Market Growth Continues
Seeking Alpha· 2025-07-31 03:20
I assigned a buy rating to The Procter & Gamble Company (NYSE: PG ) in April 2025, discussing its challenges in consumer consumption. While the company continues to face weak market demands, I think the current stock price has fullyAnalyst’s Disclosure:I/we have a beneficial long position in the shares of PG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I ha ...